Skip to main content
. 2023 Nov 9;14:1205834. doi: 10.3389/fimmu.2023.1205834

Figure 9.

Figure 9

Dapagliflozin attenuated kidney injury and alleviated renal inflammation in an ischemia/reperfusion-induced mouse CKD model. (A) Serum creatinine levels of normal (Ctrl), dapagliflozin-treated normal (Ctrl+Dapa), ischemia/reperfusion-operated (I/R), and dapagliflozin-treated I/R (I/R+Dapa) 14-week-old mice. (B) Blood urea nitrogen levels of 14-week-old mice in the Ctrl, Ctrl+Dapa, I/R, and I/R+Dapa groups. (C) blood glucose levels of 14-week-old mice in the Ctrl, Ctrl+Dapa, I/R, and I/R+Dapa groups. (D) Western blot analysis showing BTLA and ISG15 protein levels in mouse kidneys in the Ctrl, Ctrl+Dapa, I/R, and I/R+Dapa groups, with corresponding quantifications in (E). NS, not significant. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA test.